Hytacand

Candesartan cilexetil, the active ingredient in Hytacand, is an Angiotensin II receptor blocker (ARB) presented as a combination tablet for oral use. It is combined with hydrochlorothiazide, a thiazide diuretic, to treat hypertension in adult patients who require additional blood pressure control. It works by selectively blocking AT1 receptors and promoting diuresis, helping to lower blood pressure.

GNH USA supplies Hytacand as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality‑assured batches and regulatory compliance for global distribution.

Hytacand is an antihypertensive drug that acts on the renin‑angiotensin‑aldosterone system and promotes diuresis to control high blood pressure. - Essential hypertension: reduces systolic and diastolic pressure in patients with primary hypertension. - Controlled hypertension: helps achieve target blood pressure when monotherapy is insufficient. - Hypertensive patients with fluid retention: adds diuretic effect to improve overall blood pressure control.

Common Side Effects: - Dizziness: feeling light‑headed, especially after standing. - Headache: mild to moderate intensity. - Fatigue: general tiredness or lack of energy. - Increased urination: due to the diuretic component. - Electrolyte imbalance: mild changes in potassium or sodium levels. - Mild gastrointestinal discomfort: nausea or abdominal pain.

Serious or Rare Side Effects: - Severe dehydration: marked fluid loss requiring medical attention. - Hyperkalemia: dangerously high potassium levels. - Acute kidney injury: sudden decline in renal function. - Angioedema: swelling of face, lips, or throat. - Severe hypotension: dangerously low blood pressure. - Pancreatitis: inflammation of the pancreas.

Before initiating therapy, consider the following precautions: - Monitor electrolytes: check potassium and sodium levels regularly. - Assess renal function: evaluate creatinine and eGFR before and during treatment. - Use caution in elderly: increased sensitivity to blood pressure changes. - Avoid in severe hepatic impairment: limited data on safety. - Review concomitant NSAID use: may reduce antihypertensive effect. - Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Hytacand may interact with several medicines; review the following categories. Major Interactions (Avoid): - Aliskiren (in diabetic patients): risk of renal dysfunction and hyperkalemia. - Potassium‑sparing diuretics or supplements: may cause dangerous hyperkalemia. - ACE inhibitors or other ARBs: additive effect on potassium and renal function. - Lithium: increased lithium levels and toxicity. - Concomitant use with strong CYP2C9 inhibitors: may raise candesartan exposure. Moderate Interactions (Monitor Closely): - NSAIDs: may blunt antihypertensive response and affect renal function. - Beta‑blockers: additive blood pressure lowering effect. - Digoxin: monitor for signs of toxicity. - Antidiabetic agents: may require dose adjustment due to improved glycemic control. - Corticosteroids: can increase sodium retention counteracting the diuretic effect.